Healthcare
TRG Management backs Amethyst Radiotherapy
TRG will help the Romania-based provider of cancer radiotherapy treatment to expand in Europe
Mid Europa sells Walmark to PE-backed Stada
Sale ends a seven-year holding period for the GP, which invested in the company via its third fund
IK and Carlyle sell Marle to Dentressangle
GPs to sell stakes in the manufacturer of orthopaedic implants to family investment holding company Dentressangle
Ardian's Neopharmed buys pharma company MDM
Neopharmed Gentili intends to consolidate its market position and expand its product offering
Advent-backed Zentiva acquires Alvogen
Transaction is expected to close in the first quarter of 2020, subject to customary approvals
Adiuva acquires Fachklinik St Georg
Infrastructure investor Captiva has agreed to acquire the clinic's 6,000m2 of rental space
VC-backed DocPlanner buys TuoTempo
TuoTempo will operate independently and CEO Bianco will stay on with the business
Lux, Obvious Ventures lead €11.5m series-A for LabGenius
Fresh capital will be used to initiate an internal asset development programme
Benelux biotech and pharma startups attracting larger rounds
Average tickets for early-stage investments have jumped from €13m in 2017, to €20m the year after and €36m this year
Waterland-backed Schönes Leben acquires Mediko
Waterland began its care home buy-and-build strategy in 2017 with the acquisition of Compassio
PE-backed GTX Medical merges with US peer
Dutch medtech business GTX has merged with US counterpart NeuroRecovery Technologies
Pantheon to invest in KD Pharma in single-asset restructuring
Capiton IV has sold a stake in its portfolio company, Omega-3 producer KD Pharma
FSI buys minority stake in biopharma company Kedrion
GP invests via its FSI I fund, which held a final close on €1.4bn in March 2019
Atomico leads $56m round for Healx
New investors Global Brain, B-to-V and Intel Capital have invested in the biotechnology company
Synova inks first deal from latest fund with Preventx
Preventx is a provider of online-led sexual health testing and diagnostic services
Looking for the digital health tonic
Massive recent uptick in investment means 2019 is expected to reach an all-time high for digital health
BIVF, Gründerfonds Ruhr lead €12m series-A round for Abalos
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Nordic Capital's Acino acquires Takeda's primary care portfolio
Coller Capital and Goldman Sachs acquired a stake in Acino in 2018 in a GP-led secondary transaction
Ahren et al. in $16m round for Mogrify
Biotech's series-A is supported by a consortium of investors led by existing backer Ahren
Aksìa buys dental group Primo from Archimed
Sale ends a four-year holding period for French GP Archimed, which owned a 48% stake in the firm
VCs in £27m series-A for MiroBio
Advent Life Sciences, SR One, Oxford Science Innovation and Samsara Biocapital have invested
Ardian-backed Riemser buys Zaltan
Zaltan will be fully integrated in the Riemser group and operate under the name Riemser Iberia
Principia backs laser specialist Lambda
Company management retains the remaining minority holding and stays on with the business
Advent buys Industria Chimica Emiliana
GP intends to further strengthen the company's market position and boost its international expansion